US Stock MarketDetailed Quotes

GTHX G1 Therapeutics

Watchlist
  • 3.630
  • -0.010-0.27%
Close Jul 19 16:00 ET
  • 3.550
  • -0.080-2.20%
Pre 07:30 ET
189.78MMarket Cap-6050P/E (TTM)

G1 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

G1 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 17.259M--
--2024/Q2-- / 16.027M--
May 1, 20242024/Q114.476M / 15.075M--
Feb 28, 20242023/Q414.873M / 13.027M--
Nov 1, 20232023/Q312.300M / 14.229M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 17.259M--
--2024/Q2-- / 16.027M--
May 1, 20242024/Q114.476M / 15.075M--
Feb 28, 20242023/Q414.873M / 13.027M--
Nov 1, 20232023/Q312.300M / 14.229M--

Unlock Free Earnings Estimates

G1 Therapeutics Earnings Reports

  • G1 Therapeutics | 10-Q: Quarterly report

    May 1 16:25 ET

  • G1 Therapeutics | 10-K: Annual report

    Feb 28 22:28 ET

  • G1 Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:02 ET

  • G1 Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 10, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg